A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections
Namei Wu, Jiachen Zhang, Yanqiong Shen, Xinghai Zhang, Jinge Zhou, Yan Wu, Entao Li, Xiao‐Ming Meng, Xia Chuai, Sandra Chiu, Yucai Wang
Topics & Concepts
Bivalent (engine)VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Messenger RNA2019-20 coronavirus outbreakBiologyMedicineChemistryInfectious disease (medical specialty)GeneGeneticsOutbreakPathologyOrganic chemistryDiseaseMetalViral gastroenteritis research and epidemiologyRespiratory viral infections researchViral Infections and Immunology Research